Brain Monitoring Moves Beyond Fixed Blood Flow Limits

For more than half a century, doctors treating critically ill brain patients have leaned on a single, deceptively simple idea: that the brain keeps its own blood flow steady across a wide, fixed range of blood pressure. A new review published in Neurocritical Care argues that this long-standing dogma is giving way to something far more dynamic, and potentially far more powerful, a vision of bedside monitoring in which each patient’s own cerebrovascular physiology, measured continuously and noninvasively, dictates their individual perfusion targets.

The review, authored by Sérgio Brasil, Gustavo Frigieri and Fabio Silvio Taccone, traces how the field arrived at this turning point. Its starting point is Niels Lassen’s landmark 1959 review, which compiled data from several cross-sectional studies of cerebral blood flow and oxygen consumption in humans. From that compilation emerged the famous autoregulatory plateau: the notion that cerebral blood flow remains stable within a mean arterial pressure range of roughly 50 to 150 mm Hg. That graphical model became the backbone of neuroanesthesia and neurointensive care for decades, offering clinicians what the authors describe as a false sense of security that perfusion was guaranteed as long as pressures stayed inside the interval.

Lassen’s curve, however, was built on shaky foundations by modern standards. It was an extrapolation from group averages across patients with different pathologies, not longitudinal measurements within individual subjects under physiological stress. High-granularity research has since shown that the supposedly flat plateau is often an oversimplification. Even within the autoregulatory range, cerebral blood flow may vary subtly with blood pressure fluctuations, suggesting that autoregulation is an efficient buffering mechanism but not an absolute barrier. An integrative review by Willie and colleagues in 2014 went further, challenging reductionist models of human cerebral blood flow regulation by demonstrating how blood gases, blood pressure and the autonomic nervous system interact dynamically. That work corroborated four key theses: autoregulation is not a flat plateau and fails to hold perfusion constant across the traditionally accepted range of 60 to 150 mm Hg; arterial blood gases and blood pressure exert a powerful, interdependent influence on flow regulation; large conduit arteries in the neck and brain actively adjust their diameter alongside pial arterioles; and autonomic neurogenic control plays a major role in buffering sudden surges in perfusion pressure.

The clinical translation of these ideas has been equally consequential. A simplistic reading of Lassen’s work fostered the formula that cerebral perfusion pressure equals mean arterial pressure minus intracranial pressure. Yet the range of arterial pressures over which autoregulation operates most effectively appears considerably narrower than traditionally depicted, often spanning only 15 to 20 mm Hg around an individual’s optimal cerebral perfusion pressure. In acute brain injuries such as traumatic brain injury, subarachnoid hemorrhage and stroke, autoregulation is frequently impaired or completely abolished, leaving blood flow pressure-passive and directly dependent on systemic arterial pressure, with the brain exposed to the twin risks of hypoperfusion and hyperperfusion.

The pivotal technological leap came in the 1990s, when Marek Czosnyka and colleagues at Addenbrooke’s Hospital in Cambridge developed the pressure reactivity index, or PRx. Unlike flow-based methods, PRx uses the moving correlation between mean arterial pressure and intracranial pressure to infer autoregulatory state. When autoregulation is intact, a rise in arterial pressure triggers arteriolar vasoconstriction that reduces cerebral blood volume and keeps intracranial pressure stable or slightly lower, yielding a negative or near-zero correlation. When autoregulation fails, vessels behave passively: rising pressure dilates them, swelling cerebral blood volume and intracranial pressure, and producing a positive correlation. From PRx flowed a transformative application. In 2002, Steiner and colleagues showed that plotting PRx against cerebral perfusion pressure often produces a U-shaped curve whose nadir marks the pressure at which that patient’s autoregulation works best. Shorter time spent within that optimal range was associated with an increased risk of unfavorable neurological outcome, and the findings challenged the universal target of 60 to 70 mm Hg for all patients with acute brain injury. One patient may tolerate a perfusion pressure of 65 mm Hg while another needs one closer to 85 mm Hg. The phase II COGiTATE trial subsequently demonstrated that targeting an individually derived optimum through dynamic adjustment of mean arterial pressure is feasible and safe in traumatic brain injury.

Parallel work has reframed how clinicians think about intracranial pressure itself. Because bedside monitoring actually measures the pressure response to added volume, it evaluates elastance rather than compliance, although the older terminology persists. The recognition that intracranial pressure is a late symptom of exhausted volume reserve, a paradigm the authors call Monro–Kellie 4.0, incorporates active compensation across all intracranial compartments and helps explain why neuroimaging can miss dangerous pressure elevations. Analysis of the intracranial pressure pulse waveform adds granularity: a normal pulse shows three peaks, and as reserve diminishes the second tidal peak grows relative to the first percussion peak. A P2/P1 ratio above 1.2 serves as an early marker of compliance deterioration, often preceding absolute pressure rises, and the concept of an intracranial pressure dose suggests that the intensity and duration of hypertension exposure predict outcome better than isolated thresholds.

All of this, however, depended on invasive catheters, which carry infection and hemorrhage risks and leave many patients, particularly those with mild-to-moderate injuries or treated in units without neurosurgery, without neuromonitoring at all. That is where the review’s most striking development enters. A system developed in Brazil, known as B4C, uses a highly sensitive piezoelectric sensor placed on the frontotemporal skin to detect the minute expansions and retractions of the skull with each heartbeat. Contrary to the belief held in Monro and Kellie’s era, the skull is not an absolutely rigid box. The sensor captures this cranial breathing and reconstructs the intracranial pressure waveform with fidelity comparable to invasive methods, delivering metrics such as the P2/P1 ratio and time-to-peak noninvasively. Research at the Cleveland Clinic demonstrated a strong correlation, R = 0.70 with p < 0.0005, between the invasive pulse-amplitude index and the noninvasive equivalent obtained by B4C, indicating the device’s ability to capture cerebral vascular reactivity.

The newest and arguably most significant advance is the demonstration that the sensor can identify an optimal mean arterial pressure autonomously. In a multicenter study of 114 patients with different acute brain injuries, researchers compared optimal pressures derived from invasive PRx with those derived from the noninvasive P2/P1 ratio. Agreement was high, with a mean difference of only +2.00 mm Hg and a linear correlation of r = 0.905. The nadir of the compliance curve coincided with the nadir of the reactivity curve, raising the possibility of dynamic, noninvasive titration of blood pressure at the bedside. Deviations carry physiological meaning: an elevated P2/P1 ratio at low pressures may reflect compensatory vasodilation in response to inadequate perfusion, while a high ratio at elevated pressures may signal pressure-passive vasodilation and lost autoregulatory vasoconstriction, a pattern common in impaired autoregulation.

Early clinical and economic data add weight to the promise. A retrospective study at Hospital Nove de Julho compared 51 neurocritical patients managed with a B4C-guided compliance protocol against 51 patients under standard care. Mortality during intensive care unit hospitalization was 5.9 percent in the compliance-guided group versus 37.3 percent in the control group, a difference the authors report as statistically significant with p = 0.0003. Multivariable analysis identified compliance-guided management as the strongest protective factor against death, with an odds ratio of 0.0093. Recovery quality was also superior, with a lower 30-day readmission rate of 12.50 percent versus 38.70 percent and an estimated saving of approximately US $3,878 per patient. The authors themselves caution that these results, however promising, support further studies to replicate and validate the approach.

Important limitations temper the enthusiasm. Calculating PRx-derived optimal pressures requires invasive intracranial pressure monitoring, and the continuous determination demands a substantial temporal window, typically two to four hours, to capture enough spontaneous slow-wave blood pressure fluctuations, producing low real-time yield and frequent data gaps when pressure-volume variability is low. The algorithm also depends on fitting a U-shaped parabolic curve to the pressure-reactivity relationship, requiring significant variation over time, and reaching an optimal perfusion pressure does not universally prevent microvascular tissue hypoxia, so focal brain tissue oxygenation monitoring remains necessary. For the B4C sensor, agitation and decompressive craniectomy can limit accuracy, and validation in larger international cohorts is still needed. Even so, the trajectory the review charts is unmistakable: autoregulatory function is dynamic and patient-specific, noninvasive technologies are expanding access to continuous cerebrovascular assessment, and the era of one-size-fits-all pressure thresholds in neurocritical care is drawing to a close.

Subject of Research: Individualized noninvasive assessment of cerebrovascular autoregulation in neurocritical care

Article Title: The Next Era in Cerebrovascular Autoregulation Assessment?

Article References: Brasil, S., Frigieri, G., & Taccone, F. S. (2026). The Next Era in Cerebrovascular Autoregulation Assessment?. Neurocritical Care. https://doi.org/10.1007/s12028-026-02682-1

Image Credits: AI Generated

DOI: 10.1007/s12028-026-02682-1

Keywords: cerebrovascular autoregulation, neurocritical care, intracranial pressure, pressure reactivity index, optimal cerebral perfusion pressure, noninvasive monitoring, cranial pulsatility, intracranial compliance, traumatic brain injury, cerebral blood flow, Monro-Kellie doctrine, individualized perfusion targets